AbbVie, Inc. (ABBV)
205.03
-1.08
(-0.52%)
USD |
NYSE |
May 06, 16:00
204.95
-0.08
(-0.04%)
Pre-Market: 08:26
AbbVie Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -716.00M |
| Biogen, Inc. | -209.50M |
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -1.04B |
| Regeneron Pharmaceuticals, Inc. | -428.90M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | 17.82B |
| Free Cash Flow Per Share (Quarterly) | 2.756 |
| Free Cash Flow to Equity (Quarterly) | 5.447B |
| Free Cash Flow to Firm (Quarterly) | 5.404B |
| Free Cash Flow Yield | 4.90% |